ArticleVeterinary world2021
Immunomodulatory effect of the combined use of Vetosporin Zh probiotic and Gumi-malysh biologically active additive.
Article in Veterinary world, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimVarious means and methods, including probiotics and biologically active additives, have been developed and proposed for production to increase the immunobiological reactivity of the body, regardless of the etiology of its decrease. This study aimed to find out the immune status of calves during the preweaning period in association with Vetosporin Zh, Normosil, and Gumi-malysh. MATERIALS AND
methodsThe research object was 30-day-old calves of black-and-white Holstein breed. The calves were divided into four groups of 20 heads each. The calves of the first, second, and third experimental groups were treated with Normosil probiotic, Vetosporin Zh probiotic, and Vetosporin Zh probiotic in combination with Gumi-malysh, respectively. The calves in the first, second, and third experimental groups were treated with Normosil probiotic, Vetosporin Zh probiotic, and Vetosporin Zh probiotic in combination with Gumi-malysh, respectively.
resultsOn days 10 and 21 of the experiment, animal blood was collected to determine the content of total protein, protein fractions, immunoglobulins, T and B lymphocytes, phagocytic activity and a phagocytic number of neutrophils, and circulating immune complexes (CIC). The combined use of Vetosporin Zh probiotic (dose, 20 mL) with Gumi-malysh (dose, 30 mL) per animal for 30 days in 1-month-old calves contributes to the increase in the number of T lymphocytes, B lymphocytes, and immunoglobulin A (IgA) and immunoglobulin G (IgG) levels by 2.9%, 3.8%, and 0.96 and 2 g/L, respectively, while reducing the immunoglobulin M (IgM) level; an increase in the phagocytic activity of blood neutrophils and the phagocytic number by 7% and 1.8%, respectively, as well as a decrease in the CIC level with similar indicators in calves that were not treated with the agents.
conclusionThe method used in the current study helps increase the number of T and B lymphocytes, increase IgA and IgG levels while reducing IgM levels, and increase the phagocytic activity and a phagocytic number of blood neutrophils, as well as decrease the CIC level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.